Helsinn Therapeutics (U.S.), Inc.

NJ · United States · Reporting entity ID 100000151623

Total reported 2019–2025

$2.61M

#936 of 2,960 reporting companies — 0% of all reported industry payments

$1.17M in general payments across 8,772 records, plus $1.44M in research funding across 41 records.

How it breaks down

General payments $1,172,492

Research funding $1,440,834

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.